Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Autoimmune Disorders

Free Subscription 15.06.2026 1 BMC Neurol 3 Brain 1 Diabet Med 3 Diabetes Res Clin Pract 2 Intern Med 1 J Autoimmun 4 J Nephrol 7 J Neurol 1 J Pediatr Endocrinol Metab 1 J Rheumatol 4 Mult Scler 2 N Engl J Med 1 Neurologia (Engl Ed) 1 Neurology 2 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

BMC Neurol

1. AHMED AM, Mistry N, Gehad AS, Hassan AM, et al
   Inflammatory CADASIL: the cross-link between CADASIL and multiple sclerosis: a report of two cases and systematic review of the literature.
   BMC Neurol. 2026;26:373.
   PubMed         Abstract available
   
   

   
   Brain

2. ARNABOLDI PM, Becker J, Nath A, Coyle PK, et al
   Designing studies for post-treatment Lyme disease and other infection-associated chronic illnesses.
   Brain. 2026 May 18:awag016. doi: 10.1093.
   PubMed         Abstract available
   
   
3. TUR C, Susin-Calle S, Otero-Romero S, Carvajal R, et al
   Spider-MS: an individualized polyhedral prediction of multiple sclerosis prognosis.
   Brain. 2026 Jun 10:awag047. doi: 10.1093.
   PubMed         Abstract available
   
   
4. ARLT FA, Miske R, Appeltshauser L, Zinnow V, et al
   Septin multimer autoantibodies in severe motor neuropathy mimicking lower motor neuron disease.
   Brain. 2026 Jun 8:awag183. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   Diabet Med

5. KOZUCH W, Dayan R, Ablorsu E, Elker D, et al
   Hypo- and hyperglycaemia following pancreas transplantation for people with type 1 diabetes.
   Diabet Med. 2026 Apr 7:e70307. doi: 10.1111/dme.70307.
   PubMed         Abstract available
   
   

   
   Diabetes Res Clin Pract

6. DEEB A, Yaqoob N, Beck RH, Suliman S, et al
   Insulin-to-carbohydrate ratio intensification during Ramadan in young people using advanced hybrid closed-loop therapy: A prospective quasi-experimental pilot study.
   Diabetes Res Clin Pract. 2026;237:113337.
   PubMed         Abstract available
   
   
7. GILL S, Grieve N, van Heerden L, Shwed A, et al
   Behaviour change techniques and physical activity outcomes in interventions for children with type 1 diabetes: A scoping review.
   Diabetes Res Clin Pract. 2026;237:113321.
   PubMed         Abstract available
   
   
8. KATEEL R, Parida A, Chogtu B, Holla SN, et al
   Safety of GLP-1 receptor agonists in type 1 diabetes: a systematic review and meta-analysis.
   Diabetes Res Clin Pract. 2026;237:113270.
   PubMed         Abstract available
   
   

   
   Intern Med

9. IHARA Y, Umeno J, Toh C
   Gastric Polypoid Nodular Scarring Underlying Autoimmune Gastritis.
   Intern Med. 2026 Jun 11. doi: 10.2169/internalmedicine.7304.
   PubMed        
   
   
10. SAHEKI T, Harada E, Yoshimura T, Kobayashi T, et al
    Development of Graves' Disease and the Recovery of TSH Secretion during a Long-term Follow-up of Isolated TSH Deficiency.
    Intern Med. 2026 Jun 11. doi: 10.2169/internalmedicine.7555.
    PubMed         Abstract available
    
    

    
    J Autoimmun

11. SUZUKI S, Iida M, Wakahara T, Shiko Y, et al
    Long-term effectiveness, safety, and cost-effectiveness of intravenous immunoglobulin for generalized myasthenia gravis in an era of molecular targeted drugs: Insights from Japanese post-marketing surveillance.
    J Autoimmun. 2026;162:103588.
    PubMed         Abstract available
    
    

    
    J Nephrol

12. KLEIN M, Roberts V, Javaid MM
    Immunoglobulin A nephropathy-novel insights in long-term outcomes and pathophysiology leading to international guideline modification and new emerging therapies.
    J Nephrol. 2026;39:37-49.
    PubMed         Abstract available
    
    
13. KRAMER S, Vogt K, Busch M, Schmitt T, et al
    Risk stratification for renal outcomes in ANCA-associated vasculitides using established scores and histopathological criteria.
    J Nephrol. 2026;39:179-187.
    PubMed         Abstract available
    
    
14. SHOU J, Su F, Wang Y, Liao Y, et al
    Beclin-1/LC3B regulation of podocyte autophagy in IgA nephropathy via PI3K/AKT signaling.
    J Nephrol. 2026 Jun 10:aajag006. doi: 10.1093.
    PubMed         Abstract available
    
    
15. JAIN A, Pabba M, Pal A, Beers K, et al
    Tumor necrosis factor inhibitor-associated IgA nephropathy in the setting of Behcet's disease: Lessons for the clinical nephrologist.
    J Nephrol. 2026 Jun 8:aajag053. doi: 10.1093.
    PubMed        
    
    

    
    J Neurol

16. MA LL, Dai K, Ma XM, Liu YY, et al
    Clinical characteristics of late-onset adult autoimmune glial fibrillary acidic protein astrocytopathy: a retrospective cohort study.
    J Neurol. 2026;273:377.
    PubMed         Abstract available
    
    
17. XING C, Li W, Tian R, Hu M, et al
    Efgartigimod as adjunctive therapy in refractory autoimmune glial fibrillary acidic protein astrocytopathy: a case series.
    J Neurol. 2026;273:385.
    PubMed         Abstract available
    
    
18. GUGER M, Enzinger C, Heschl B, Di Pauli F, et al
    The impact of age on efficacy and safety of disease modifying treatment-insights from the Austrian Multiple Sclerosis Treatment Registry.
    J Neurol. 2026;273:392.
    PubMed         Abstract available
    
    
19. HOF SN, Keytsman E, Fuchs TAN, Wessels MHJ, et al
    What if it is the eyes? The effect of eye movement disorders on cognitive testing in MS.
    J Neurol. 2026;273:355.
    PubMed         Abstract available
    
    
20. REUTER E, Luerweg J, Katsimpoura M, Haselon J, et al
    Virtual reality-based oculography detects internuclear ophthalmoplegia in multiple sclerosis and other neurological disorders.
    J Neurol. 2026;273:372.
    PubMed         Abstract available
    
    
21. ESPOSITO F, Misra K, Doyle F, Clarelli F, et al
    Distinct age-related pattern of mitochondrial somatic mutations across multiple sclerosis phenotypes.
    J Neurol. 2026;273:374.
    PubMed         Abstract available
    
    
22. FOTTINGER F, Krajnc N, Berek K, Nolte JP, et al
    Integration of retinal layer thinning into NEDA-3 predicts disability progression in multiple sclerosis.
    J Neurol. 2026;273:382.
    PubMed         Abstract available
    
    

    
    J Pediatr Endocrinol Metab

23. OZTURK IS, Gurbuz F, Ugras E
    Psychosocial adaptation of parents of children with type 1 diabetes: a cross-sectional study.
    J Pediatr Endocrinol Metab. 2026;39:449-456.
    PubMed         Abstract available
    
    

    
    J Rheumatol

24. ELOSEILY E, Romankevych I, Sabit T, Berklite L, et al
    Hepatic Manifestations in Systemic Juvenile Idiopathic Arthritis and Macrophage Activation Syndrome.
    J Rheumatol. 2026;53:669-678.
    PubMed         Abstract available
    
    

    
    Mult Scler

25. MCCURDY S, Sheng E, Jalaleddini K, Datta G, et al
    Longitudinal short-term assessments of single- and multi-protein disease activity biomarkers to determine reliability and the minimum detectable change in people with clinically stable RRMS.
    Mult Scler. 2026;32:711-721.
    PubMed         Abstract available
    
    
26. TALLANTYRE EC, Apap Mangion S, Teunissen CE
    A framework for blood biomarker discovery in MS.
    Mult Scler. 2026;32:661-669.
    PubMed         Abstract available
    
    
27. CHEN H, Cortese M, Flores-Torres MH, Chen X, et al
    Comorbidities and lifestyle changes as predictors of the multiple sclerosis prodrome: A prospective cohort study.
    Mult Scler. 2026 Jun 10:13524585261454827. doi: 10.1177/13524585261454827.
    PubMed         Abstract available
    
    
28. HAMEDANI M, Lombardi G, Boffa G, Pistarini C, et al
    Task-oriented virtual reality and brain functional plasticity in progressive multiple sclerosis: A randomized controlled trial on upper limb rehabilitation.
    Mult Scler. 2026 Jun 9:13524585261450820. doi: 10.1177/13524585261450820.
    PubMed         Abstract available
    
    

    
    N Engl J Med

29. BASTARD P, Casanova JL
    Autoantibodies against Cytokines - From Infection to Inflammation.
    N Engl J Med. 2026;394:2270-2273.
    PubMed        
    
    
30. GHARAHDAGHI N, Yeh PJ, Ceron-Gutierrez L, Griffin H, et al
    Interleukin-10 Autoantibodies and HLA-DRB1*01:03 in Inflammatory Bowel Disease.
    N Engl J Med. 2026;394:2212-2222.
    PubMed         Abstract available
    
    

    
    Neurologia (Engl Ed)

31. MASSONS M, Rodriguez-Vazquez A, Mesa A, Amaro S, et al
    Bilateral carotid arteriopathy associated with Graves Disease: a case report.
    Neurologia (Engl Ed). 2026 May 25:502089. doi: 10.1016/j.nrleng.2026.502089.
    PubMed        
    
    

    
    Neurology

32. GUINEBRETIERE O, Yang F, Wei D, Calonge Q, et al
    Drivers of Rising Prevalence in Major Motor Neurodegenerative Diseases: Temporal Trends in Sweden and France (2003-2022).
    Neurology. 2026;107:e218072.
    PubMed         Abstract available
    
    

    
    PLoS One

33. MARIKI A, Kohlmeier KA, Mousavi SM, Keyhani A, et al
    Fasciola hepatica excretory-secretory products attenuate demyelination and reduce neuroinflammation in the Cuprizone -induced multiple sclerosis model.
    PLoS One. 2026;21:e0349675.
    PubMed         Abstract available
    
    
34. MARTIN-BAEZ MY, Diaz-Gonzalez CM
    Preschool and primary school teachers' attitudes toward students with type 1 diabetes: A cross-sectional study.
    PLoS One. 2026;21:e0350813.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Autoimmune Disorders is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum